Abstract
Background/Aims: Vaccination with the quadrivalent human papillomavirus (HPV) vaccine presents an opportunity to reduce the burden of conditions caused by HPV types 6, 11, 16 and 18. Despite increases in HPV vaccine initiation since its introduction in 2006, the 3-dose series completion rate among age-eligible males and females remains low. Provider recommendation has been identified as one of the strongest influences on HPV vaccine initiation. However, limited research has examined the contribution of provider factors to HPV vaccine completion. The purpose of this study was to gain an understanding of barriers and facilitators to HPV vaccine series completion from the perspective of immunization providers.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
